CompanyJiangsu Bioperfectus Technologies Co. Ltd
China
As a leading In Vitro Diagnostic (IVD) product supplier in China, Bioperectus specializes in developing, manufacturing and selling IVD reagents, diagnostic instruments as well as providing IVD diagnostic services. Currently, Bioperfectus has realized integrated business model by combining reagent, instrument and service.
Private/Public:
public
Phone:0523-86201616
Fax:0523-86201617
Email:[email protected]
Website:https://www.bioperfectus.com/
Address:3rd floor, Block G19, No.1 Yaocheng Avenue，Taizhou, Jiangsu, China
2010
Since
1
Country
1
Top Service Category
58
Sub-Service Categories
Therapeutic Categories
Main Disease Areas
Diagnostics
Diagnostic assay development/manufacturing
- Diagnostics IVD/LTD Development Services
- Diagnostic analytical performance services
- Diagnostic assay verification and validation
- Diagnostic clinical validation
- Diagnostic final kit box-packaging
- Diagnostic formulation development
- Diagnostic reagent development
- Immunoassay development
- Molecular IVD/LTD test/kit development
- POC test kit development
Diagnostic Product Offerings
- Assay reagents and probes
- Specific Diagnostic Kit (IVD) Product Offerings
- Forensic test kits
- Infectious Disease Test Kits
- POC Diagnostic Test Kits
Diagnostic Testing Services - Genomic/Non-genomic
China
- (17.Jun.2022) Bioperfectus Real-Time PCR Systems Included in FDA-Listed for IVD Testing
- (06.Jun.2022) Try Our New Automated Nucleic Acid Extraction Workstation SAW-96 Now
- (24.May.2022) Good News! CE Mark Approval for Bioperfectus Monkeypox Virus Real Time PCR Kit
- (24.May.2022) CE Mark Approval for Bioperfectus Monkeypox Virus Real Time PCR Kit
- (23.May.2022) Emergency Release of Bioperfectus Monkeypox Virus Real Time PCR Kit
- (23.May.2022) Emergency Release of Bioperfectus Monkeypox Virus Real Time PCR Kit
- (12.May.2022) Compact and Powerful, SSNP-2000B Promotes Molecular Detection Ability
- (25.Apr.2022) Bioperfectus and Red Cross Taizhou Raised Donation of 100,000 COVID-19 Self Antigen Tests to Hongkong
- (22.Apr.2022) Two New Arrival Members Strengthen Bioperfectus Total PCR Solution
- (12.Apr.2022) Bioperfectus SSNP-2000B Nucleic Acid Extraction System Wins IF Design Award 2022
- (25.Mar.2022) Bioperfectus Acquired ISO 9001:2005 Certification
- (01.Mar.2022) Bioperfectus Together with Brunei to Fight and Defeat COVID-19
- (24.Feb.2022) Bioperfectus Jointly Cooperate with FIND to Accelerate the COVID-19 Self-Testing Capacity in LMICs
- (09.Feb.2022) Market Approval for Bioperfectus COVID-19 Self-Test in Portugal
- (08.Feb.2022) Bioperfectus COVID-19 Ag Self-Test Approval in Italy
- (05.Feb.2022) Bioperfectus COVID-19 Self Ag Test is Now Available in Spain
- (27.Jan.2022) Bioperfectus Mass Distribution of Rapid COVID-19 Tests in Israel Begins
- (28.Dec.2021) Bioperfectus Obtained CE Mark for the SARS-CoV-2 Antigen Rapid Self-Test
- (06.Dec.2021) Bioperfectus Whole Blood DNA Extraction Kit is Available Now!
- (24.Nov.2021) Bioperfectus Launches a New RT-PCR Kit to Detect COVID-19 New Variant"Omicron"
- (11.Nov.2021) New Member of COVID-19 Variant Detection Kit
- (05.Aug.2021) A Fight Against COVID-19：Bioperfectus Total Diagnostic Solution for COVID-19
- (27.Jul.2021) Bioperfectus Launched NEW RUO Product to Confront SARS-CoV-2 Delta Variant
- (15.Jul.2021) Bioperfectus COVID-19 Self Antigen Test Received the Approval of BfArM
- (02.Jul.2021) Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit Successfully Passed PEI Evaluation